Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trial

Publisher Website

Abstract

An abstract is not available for this record. Please visit the publisher website for more details.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now